Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma. Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback